BIO has released a new and improved mobile app for the BIO One-on-One Partnering™ system. After intensive surveys and interviews with attendees who have engaged in partnering at BIO business development & investor events around the world, we revamped our partnering mobile app to make the…

Alzheimer’s is one of the most feared diseases in the world. Despite many attempts to find an effective therapy to prevent or delay its effects, the disease remains largely untreatable. Many of us know someone with Alzheimer’s. For me, it was my father who was faced with early onset of the disease…

After receiving a record number of nominations, we are pleased to announce our winners for the 2019 Buzz of BIO contest of the BIO Investor Forum!  WINNER: Early Stage Entrepreneur   SciBac creates live biotherapeutics that treat antibiotic resistant disease while fortifying the…

The 2020 BIO International Convention is heading back to San Diego, California next June, and planning is well underway! First order of business? Announcing our theme. This year we reflect on the passion, drive and risk-taking of an industry that consistently strives to accomplish things that…

The 5th BIO Latin America was held September 3-4 in the largest metropolis in the Western Hemisphere - Sao Paulo, Brazil. The BIO Latin America Conference, co-hosted by BIO and Biominas Brazil, has solidified itself as the premier life sciences meeting in the Latin America, welcoming over 675…

“For years of my life, I’ve let myself be defined by the words of others. Addict, junkie, criminal. With all those labels, it’s so much harder to go get tested for hepatitis C and add one more notch to that.” Those are the powerful words of Cat, a harm reduction advocate from North Carolina—one of…

The fight against HIV has moved off the front pages. Advancements in antiretroviral drugs are allowing people living with HIV to live normal lives. By reducing the “viral load”, these treatments give the immune system a chance to recover and allow the body to fight off infections and certain…

Innovate Biopharmaceuticals has had more meetings through BIO’s One-on-One Partnering™ than they can count. In fact, it is the principal way the company meets candidates for both in-licensing and out-licensing arrangements. Participating for at least six years, the company points out that in the…

Is your company seeking a next round of financing or hoping to make the valuable connection needed to take your product into the next phase? Nominate your company and enter the Buzz of BIO contest at the BIO Investor Forum. Ten biotechs will be selected in each of the three categories, "Early Stage…

Keith Ignotz knows the power of a good story. The President & CEO of OcuMedic—an early stage biotech company developing a novel pre-and post-eye surgery treatment to replace eye drops—has made significant inroads telling the OcuMedic story since he assumed his role in early 2018. Some of his…